microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (1) , 5632-5640
Abstract
Acute coronary syndrome (ACS) is one of the main syndromes of coronary artery disease with high mortality. The identification of biomarkers associated with disease occurrence and progression could improve early detection and risk prediction. This study was aimed to reveal the clinical significance and function of miR-3646 in ACS. The expression of miR-3646 was evaluated in ACS patients, healthy volunteers, and non-ACS patients and estimated the clinical significance of miR-3646. The ACS modeling rats were also established in this study to explore the potential mechanism underlying the function of miR-3646. miR-3646 was upregulated in ACS patients compared with healthy volunteers and non-ACS patients. The expression of miR-3646 was positively correlated with the severity and progression of ACS patients and could discriminate ACS patients from healthy volunteers and non-ACS patients. The knockdown of miR-3646 could reverse the inflammatory response induced by ACS.miR-3646 serves as a diagnostic biomarker for ACS. The knockdown of miR-3646 could alleviate ACS by reversing inflammatory response. These results provide a potential therapeutic target of ACS.Keywords
Funding Information
- Zibo City Key Research and Development (2019ZC060015)
This publication has 38 references indexed in Scilit:
- Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitationHealth and Quality of Life Outcomes, 2017
- MiR-206 Suppresses the Progression of Coronary Artery Disease by Modulating Vascular Endothelial Growth Factor (VEGF) ExpressionMedical Science Monitor, 2016
- Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic reviewCardiovascular Research, 2016
- miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.2016
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling PathwayPLOS ONE, 2016
- Role of Oral Anticoagulants in Patients After an Acute Coronary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- MicroRNAs Control Vascular Endothelial Growth Factor SignalingCirculation Research, 2012
- Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?European Heart Journal, 2011
- Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from OmanCurrent Medical Research and Opinion, 2011
- Enzyme Immunoassay (EIA)/Enzyme-Linked Immunosorbent Assay (ELISA)Clinical Chemistry, 2005